The HIV-coinfected patient: Managing viral hepatitisSULKOWSKI, Mark S.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, issn 1525-4135, 37 p., SUP2Serial Issue

Diagnosis and management of cirrhosis in coinfected patientsBONACINI, Maurizio.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, issn 1525-4135, S38-S46, SUP2Article

Hepatitis B in the HIV-coinfected patientBENHAMOU, Yves.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, issn 1525-4135, S57-S65, SUP2Article

Hepatitis C in the HIV-infected personSULKOWSKI, Mark S; THOMAS, David L.Annals of internal medicine. 2003, Vol 138, Num 3, pp 197-207, issn 0003-4819, 11 p.Article

Management of Hepatic Complications in HIV-Infected PersonsSULKOWSKI, Mark S.The Journal of infectious diseases. 2008, Vol 197, issn 0022-1899, S279-S293, SUP3Article

Hepatitis C in the HIV-infected patientMCGOVERN, Barbara H.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, issn 1525-4135, S47-S56, SUP2Article

Anemia in the treatment of hepatitis C virus infectionSULKOWSKI, Mark S.Clinical infectious diseases. 2003, Vol 37, pp S315-S322, issn 1058-4838, SUP4Article

Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitorsSULKOWSKI, Mark S.Clinical infectious diseases. 2004, Vol 38, pp S90-S97, issn 1058-4838, SUP2Conference Paper

Treatment of chronic hepatitis B in HIV-infected persons : Thinking outside the black boxTHIO, Chloe L; SULKOWSKI, Mark S; THOMAS, David L et al.Clinical infectious diseases. 2005, Vol 41, Num 7, pp 1035-1040, issn 1058-4838, 6 p.Article

Needlestick transmission of Hepatitis CSULKOWSKI, Mark S; RAY, Stuart C; THOMAS, David L et al.JAMA, the journal of the American Medical Association. 2002, Vol 287, Num 18, pp 2406-2413, issn 0098-7484Article

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 InfectionAFDHAL, Nezam; REDDY, K. Rajender; LALEZARI, Jacob et al.The New England journal of medicine. 2014, Vol 370, Num 16, pp 1483-1493, issn 0028-4793, 11 p.Article

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceDONGLIANG GE; FELLAY, Jacques; SULKOWSKI, Mark et al.Nature (London). 2009, Vol 461, Num 7262, pp 399-401, issn 0028-0836, 3 p.Article

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionMCHUTCHISON, John G; EVERSON, Gregory T; GORDON, Stuart C et al.The New England journal of medicine. 2009, Vol 360, Num 18, pp 1827-1838, issn 0028-4793, 12 p.Article

Care of HIV patients with chronic hepatitis B : updated recommendations from the HIV-Hepatitis B Virus International PanelSORIANO, Vincent; PUOTI, Massimo; PETERS, Marion et al.AIDS (London). 2008, Vol 22, Num 12, pp 1399-1410, issn 0269-9370, 12 p.Article

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers : The SHASTA indexKELLEHER, Thomas B; MEHTA, Shruti H; BHASKAR, Ramakrishnan et al.Journal of hepatology. 2005, Vol 43, Num 1, pp 78-84, issn 0168-8278, 7 p.Article

Role of liver biopsy in management of chronic hepatitis C: A systematic reviewGEBO, Kelly A; HERLONG, H. Franklin; TORBENSON, Michael S et al.Hepatology (Baltimore, Md.). 2002, Vol 36, Num 5, pp S161-S172, issn 0270-9139, SUP1Conference Paper

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokineticsLAWITZ, Eric; SULKOWSKI, Mark; MILLER, Michelle et al.Antiviral research. 2013, Vol 99, Num 3, pp 214-220, issn 0166-3542, 7 p.Article

Hepatitis C Viremia and the Risk of Chronic Kidney Disease in HIV-Infected IndividualsLUCAS, Gregory M; YUEZHOU JING; MOORE, Richard D et al.The Journal of infectious diseases. 2013, Vol 208, Num 8, pp 1240-1249, issn 0022-1899, 10 p.Article

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis CFELLAY, Jacques; THOMPSON, Alexander J; WANER, Amelia et al.Nature (London). 2010, Vol 464, Num 7287, pp 405-408, issn 0028-0836, 4 p.Article

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapySULKOWSKI, Mark; WRIGHT, Teresa; ROSSI, Stephen et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 3, pp 214-224, issn 0009-9236, 11 p.Article

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialSULKOWSKI, Mark; POL, Stanislas; WENNING, Larissa et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 597-605, issn 1473-3099, 9 p.Article

Care of patients coinfected with HIV and hepatitis C virus : 2007 updated recommendations from the HCV-HIV International PanelSORIANO, Vincent; PUOTI, Massimo; ROCKSTROH, Juergen et al.AIDS (London). 2007, Vol 21, Num 9, pp 1073-1089, issn 0269-9370, 17 p.Article

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infectionDORE, Gregory J; TORRIANI, Francesca J; GODOFSKY, Eliot W et al.AIDS (London). 2007, Vol 21, Num 12, pp 1555-1559, issn 0269-9370, 5 p.Article

Pilot study of low-dose interleukin-2, pegylated interferon-α2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infectionGLESBY, Marshall J; BASSETT, Roland; ALSTON-SMITH, Beverly et al.The Journal of infectious diseases. 2005, Vol 191, Num 5, pp 686-693, issn 0022-1899, 8 p.Article

Page / 4